Electrophysiology
Leadless pacing portfolio
Micra™ AV2 and Micra™ VR2 leadless pacemakers are the world’s smallest pacemakers1 for bradyarrhythmia management.
A decade of innovation.
Micra™ devices have been providing an unmatched leadless pacing experience for bradycardia patients for more than 10 years. Relentless innovation over the past decade has led to improved battery longevity and smarter algorithms, meaning most patients are projected to only need one device for life.2
Enhanced delivery system
The updated delivery system now has a rounded catheter tip with more surface area to decrease tip pressure during device implant.3 Micra™ AV2 and Micra™ VR2 devices are implanted with the same streamlined procedure that has been utilized by over 10,000 trained Micra™ physicians worldwide.4
Clinical evidence and real-world experience
Micra™ leadless pacemakers were first commercialized more than 10 years ago and have since been implanted in more than 300,000 patients worldwide.4 Medtronic is following more than 40,000 patients in clinical research activities and there have been more than 350 manuscripts published across the globe.4 Visit Medtronic Academy to learn more about our robust evidence.
> 99%
Implant success rate across multiple clinical studies5–7
↓ 53%
Reduction in both major complications and system revisions through three years†,8
< 5%
Low rates of major complications and system revisions sustained through five years†,8
Micra™ leadless pacemaker videos
Related links
Educational resources on Medtronic Academy
Access interactive courses, videos, and educational resources to extend your learning on Micra™ leadless pacemaker.
